S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NYSE:MDT

Medtronic Stock Forecast, Price & News

$116.58
-1.33 (-1.13 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$116.56
Now: $116.58
$117.76
50-Day Range
$111.18
MA: $115.85
$119.71
52-Week Range
$72.13
Now: $116.58
$121.41
Volume3.03 million shs
Average Volume4.02 million shs
Market Capitalization$156.92 billion
P/E Ratio44.50
Dividend Yield1.97%
Beta0.7
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Medtronic logo

MarketRank

Overall MarketRank

2.69 out of 5 stars

Medical Sector

6th out of 1,925 stocks

Electromedical Equipment Industry

1st out of 61 stocks

Analyst Opinion: 2.5Community Rank: 3.3Dividend Strength: 4.2Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP58505510
Phone353-1438-1700
Employees90,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.91 billion
Cash Flow$6.50 per share
Book Value$37.96 per share

Profitability

Net Income$4.79 billion

Miscellaneous

Outstanding Shares1,346,020,000
Market Cap$156.92 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableOptionable
$116.58
-1.33 (-1.13 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medtronic (NYSE:MDT) Frequently Asked Questions

How has Medtronic's stock price been impacted by COVID-19?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MDT stock has increased by 26.1% and is now trading at $116.58.
View which stocks have been most impacted by COVID-19
.

Is Medtronic a buy right now?

24 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 3 hold ratings, 20 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Medtronic?

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medtronic wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Medtronic's CEO?

6,978 employees have rated Medtronic CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Medtronic's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Medtronic
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) issued its quarterly earnings data on Monday, November, 23rd. The medical technology company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.80 by $0.22. The medical technology company earned $7.65 billion during the quarter, compared to the consensus estimate of $7.05 billion. Medtronic had a return on equity of 9.71% and a net margin of 12.69%. During the same period last year, the company posted $0.45 earnings per share.
View Medtronic's earnings history
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Monday, December 14th. Investors of record on Tuesday, December 22nd will be given a dividend of $0.58 per share on Friday, January 15th. This represents a $2.32 annualized dividend and a dividend yield of 1.99%. The ex-dividend date is Friday, December 18th.
View Medtronic's dividend history
.

Is Medtronic a good dividend stock?

Medtronic pays an annual dividend of $2.32 per share and currently has a dividend yield of 1.97%. Medtronic has been increasing its dividend for 44 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Medtronic is 50.54%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Medtronic will have a dividend payout ratio of 39.86% next year. This indicates that Medtronic will be able to sustain or increase its dividend.
View Medtronic's dividend history.

What price target have analysts set for MDT?

24 analysts have issued 1 year target prices for Medtronic's shares. Their forecasts range from $92.00 to $140.00. On average, they anticipate Medtronic's share price to reach $122.30 in the next year. This suggests a possible upside of 4.9% from the stock's current price.
View analysts' price targets for Medtronic
or view Wall Street analyst' top-rated stocks.

Are investors shorting Medtronic?

Medtronic saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 5,650,000 shares, a decrease of 17.2% from the December 15th total of 6,820,000 shares. Based on an average daily volume of 4,550,000 shares, the days-to-cover ratio is presently 1.2 days.
View Medtronic's Short Interest
.

Who are some of Medtronic's key competitors?

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Mr. Geoffrey Straub Martha, CEO & Chairman (Age 50, Pay $1.68M)
  • Ms. Karen L. Parkhill, Exec. VP & CFO (Age 55, Pay $1.81M)
  • Mr. Bradley E. Lerman, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64, Pay $1.74M)
  • Mr. Michael J. Coyle, Exec. VP and Group Pres of Cardiac & Vascular Group (Age 58, Pay $2.09M)
  • Mr. Mark Ploof, Sr. VP of Global Operations and Bus. Services
  • Dr. Richard E. Kuntz, Sr. VP & Chief Medical and Scientific Officer (Age 63)
  • Mr. Sean Lennon, Chief Information Officer
  • Mr. Ryan Weispfenning, VP of Investor Relations
  • Ms. Marguerite Copel, PR & Interim Chief Communications Officer
  • Ms. Carol A. Surface, Sr. VP & Chief HR Officer (Age 54)

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a number of retail and institutional investors. Top institutional investors include Pendal Group Limited (0.31%), Manning & Napier Group LLC (0.10%), Boston Trust Walden Corp (0.04%), Atalanta Sosnoff Capital LLC (0.04%), Gateway Investment Advisers LLC (0.04%) and Donaldson Capital Management LLC (0.03%). Company insiders that own Medtronic stock include Bradley E Lerman, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert John White.
View institutional ownership trends for Medtronic
.

Which major investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including Pendal Group Limited, Hexavest Inc., Gateway Investment Advisers LLC, Crossmark Global Holdings Inc., Manning & Napier Group LLC, Avantax Advisory Services Inc., State of Alaska Department of Revenue, and Baldwin Brothers Inc. MA. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Carol A Surface, Hoedt Rob Ten, Karen L Parkhill, Omar Ishrak, and Robert John White.
View insider buying and selling activity for Medtronic
or view top insider-selling stocks.

Which major investors are buying Medtronic stock?

MDT stock was purchased by a variety of institutional investors in the last quarter, including Atalanta Sosnoff Capital LLC, Dudley & Shanley Inc., TIAA FSB, Grassi Investment Management, Rhenman & Partners Asset Management AB, Pacer Advisors Inc., Nexus Investment Management ULC, and Oak Harvest Investment Services. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic
or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $116.58.

How big of a company is Medtronic?

Medtronic has a market capitalization of $156.92 billion and generates $28.91 billion in revenue each year. The medical technology company earns $4.79 billion in net income (profit) each year or $4.59 on an earnings per share basis. Medtronic employs 90,000 workers across the globe.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]

This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.